{"id":43106,"date":"2020-05-13T08:01:33","date_gmt":"2020-05-13T12:01:33","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=43106"},"modified":"2020-05-13T02:52:07","modified_gmt":"2020-05-13T06:52:07","slug":"johnson-johnson-nysejnj-targets-at-least-1-billion-vaccines-in-2021","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/johnson-johnson-nysejnj-targets-at-least-1-billion-vaccines-in-2021-43106","title":{"rendered":"Johnson &#038; Johnson (NYSE:JNJ) Targets at least 1 Billion Vaccines in 2021"},"content":{"rendered":"<p>Johnson &amp; Johnson (NYSE:JNJ) is working on a vaccine with a goal of 1 billion tests in 2021. <a href=\"https:\/\/abcnews.go.com\/Politics\/drug-treatment-stopgap-vaccine-eradicate-coronavirus-johnson-johnsons\/story?id=70598317\" target=\"_blank\" rel=\"noopener noreferrer\">According<\/a> to Dr. Paul Stoffels, the Chief Scientific Officer at J&amp;J, the company \u201cis increasing its manufacturing and preparing for clinical trials in September.&#8221; The clinical trials should provide sufficient data to facilitate development of the vaccines in 2021.<\/p>\n<p>On 30 March 2020, JNJ <a href=\"https:\/\/www.jnj.com\/johnson-johnson-announces-a-lead-vaccine-candidate-for-covid-19-landmark-new-partnership-with-u-s-department-of-health-human-services-and-commitment-to-supply-one-billion-vaccines-worldwide-for-emergency-pandemic-use\" target=\"_blank\" rel=\"noopener noreferrer\">announced<\/a> the release of a COVID-19 vaccine candidate. In the press release, the company outlined the expectations to start clinical trials in September 2020 at the latest. The work towards the vaccine is a collaborative effort between JNJ and BARDA. The company revealed that plans were underway to expand the vaccine manufacturing capabilities in the United States. As of April 2020, the company was targeting to produce between 600 million and 900 million doses of vaccine in 12 months.<\/p>\n<p><strong>Will the vaccine defeat the virus?<\/strong><\/p>\n<p>Appearing on the ABC&#8217;s &#8220;This Week,&#8221; Dr. Stoffels noted the challenges of fighting COVID-19. <a href=\"https:\/\/twitter.com\/ThisWeekABC\/status\/1259490446427992064\">According<\/a> to Dr. Stoffels, COVID-19 is spreading fast in the US and abroad. Coupled with the fact that scientists are still learning more about the virus, COVID-19 could be here for a long time. Dr. Stoffels was reacting to the remarks by President Donald Trump, <a href=\"https:\/\/thehill.com\/homenews\/administration\/496876-positive-coronavirus-cases-shake-white-house\" target=\"_blank\" rel=\"noopener noreferrer\">who said<\/a> the pandemic would pass &#8220;with or without a vaccine.&#8221;<\/p>\n<p>Medical experts <a href=\"https:\/\/www.washingtonpost.com\/business\/2020\/05\/11\/coronavirus-vaccine-global-supply\/\" target=\"_blank\" rel=\"noopener noreferrer\">are in agreement<\/a> with Dr. Stoffels that COVID-19 might stay with us for longer. A likely scenario is that the virus will mutate into a stubborn and permanent medical issue for years. If it so happens, none of the vaccines in development today or later will defeat COVID-19. Instead, we may succeed to slow the spread of the virus by establishing herd immunity.<\/p>\n<p><strong>A race against time<\/strong><\/p>\n<p>JNJ is not the only entity working towards a vaccine for COVID-19. On 24 April 2020, Oxford University <a href=\"https:\/\/www.sciencealert.com\/oxford-university-has-just-launched-a-human-trial-of-a-potential-covid-19-vaccine\" target=\"_blank\" rel=\"noopener noreferrer\">rolled out<\/a> the first human trials for a coronavirus vaccine. At the time, there were seven vaccine candidate that were in clinical trial phase. The Oxford University trial involved 1,112 participants. Even as scientists ramp up the effort towards coronavirus vaccine, the death toll is rising. Johns Hopkins University <a href=\"https:\/\/coronavirus.jhu.edu\/map.html\" target=\"_blank\" rel=\"noopener noreferrer\">figures<\/a> show that 286,615 people worldwide have so far succumbed while the infection tops 4 million.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Johnson &amp; Johnson (NYSE:JNJ) is working on a vaccine with a goal of 1 billion tests in 2021. According to Dr. Paul Stoffels, the Chief [&hellip;]<\/p>\n","protected":false},"author":32,"featured_media":42812,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[2236],"tags":[14266,12267,3420,1744,14329],"stock_ticker":[14213],"class_list":["post-43106","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-business","tag-covid-19","tag-donald-trump","tag-johnson-johnson","tag-johnson-johnson-nysejnj","tag-nysejnjj","stock_ticker-jnj","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Johnson &amp; Johnson (NYSE:JNJ) Targets at least 1 Billion Vaccines in 2021 - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/johnson-johnson-nysejnj-targets-at-least-1-billion-vaccines-in-2021-43106\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Johnson &amp; Johnson (NYSE:JNJ) Targets at least 1 Billion Vaccines in 2021 - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Johnson &amp; Johnson (NYSE:JNJ) is working on a vaccine with a goal of 1 billion tests in 2021. According to Dr. Paul Stoffels, the Chief [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/johnson-johnson-nysejnj-targets-at-least-1-billion-vaccines-in-2021-43106\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2020-05-13T12:01:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/02\/Johnson-Johnson.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"620\" \/>\n\t<meta property=\"og:image:height\" content=\"413\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Greg Folin\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Greg Folin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/johnson-johnson-nysejnj-targets-at-least-1-billion-vaccines-in-2021-43106#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/johnson-johnson-nysejnj-targets-at-least-1-billion-vaccines-in-2021-43106\"},\"author\":{\"name\":\"Greg Folin\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e\"},\"headline\":\"Johnson &#038; Johnson (NYSE:JNJ) Targets at least 1 Billion Vaccines in 2021\",\"datePublished\":\"2020-05-13T12:01:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/johnson-johnson-nysejnj-targets-at-least-1-billion-vaccines-in-2021-43106\"},\"wordCount\":367,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/johnson-johnson-nysejnj-targets-at-least-1-billion-vaccines-in-2021-43106#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/02\/Johnson-Johnson.jpg\",\"keywords\":[\"COVID-19\",\"Donald trump\",\"Johnson &amp; Johnson\",\"Johnson &amp; Johnson (NYSE:JNJ)\",\"NYSE:JNJJ\"],\"articleSection\":[\"Business\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/johnson-johnson-nysejnj-targets-at-least-1-billion-vaccines-in-2021-43106\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/johnson-johnson-nysejnj-targets-at-least-1-billion-vaccines-in-2021-43106\",\"name\":\"Johnson & Johnson (NYSE:JNJ) Targets at least 1 Billion Vaccines in 2021 - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/johnson-johnson-nysejnj-targets-at-least-1-billion-vaccines-in-2021-43106#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/johnson-johnson-nysejnj-targets-at-least-1-billion-vaccines-in-2021-43106#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/02\/Johnson-Johnson.jpg\",\"datePublished\":\"2020-05-13T12:01:33+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/johnson-johnson-nysejnj-targets-at-least-1-billion-vaccines-in-2021-43106#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/johnson-johnson-nysejnj-targets-at-least-1-billion-vaccines-in-2021-43106\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/johnson-johnson-nysejnj-targets-at-least-1-billion-vaccines-in-2021-43106#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/02\/Johnson-Johnson.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/02\/Johnson-Johnson.jpg\",\"width\":620,\"height\":413},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/johnson-johnson-nysejnj-targets-at-least-1-billion-vaccines-in-2021-43106#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Johnson &#038; Johnson (NYSE:JNJ) Targets at least 1 Billion Vaccines in 2021\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e\",\"name\":\"Greg Folin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg\",\"caption\":\"Greg Folin\"},\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/greg-folin\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Johnson & Johnson (NYSE:JNJ) Targets at least 1 Billion Vaccines in 2021 - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/johnson-johnson-nysejnj-targets-at-least-1-billion-vaccines-in-2021-43106","og_locale":"en_US","og_type":"article","og_title":"Johnson & Johnson (NYSE:JNJ) Targets at least 1 Billion Vaccines in 2021 - Wall Street PR","og_description":"Johnson &amp; Johnson (NYSE:JNJ) is working on a vaccine with a goal of 1 billion tests in 2021. According to Dr. Paul Stoffels, the Chief [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/johnson-johnson-nysejnj-targets-at-least-1-billion-vaccines-in-2021-43106","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2020-05-13T12:01:33+00:00","og_image":[{"width":620,"height":413,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/02\/Johnson-Johnson.jpg","type":"image\/jpeg"}],"author":"Greg Folin","twitter_misc":{"Written by":"Greg Folin","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/johnson-johnson-nysejnj-targets-at-least-1-billion-vaccines-in-2021-43106#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/johnson-johnson-nysejnj-targets-at-least-1-billion-vaccines-in-2021-43106"},"author":{"name":"Greg Folin","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e"},"headline":"Johnson &#038; Johnson (NYSE:JNJ) Targets at least 1 Billion Vaccines in 2021","datePublished":"2020-05-13T12:01:33+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/johnson-johnson-nysejnj-targets-at-least-1-billion-vaccines-in-2021-43106"},"wordCount":367,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/johnson-johnson-nysejnj-targets-at-least-1-billion-vaccines-in-2021-43106#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/02\/Johnson-Johnson.jpg","keywords":["COVID-19","Donald trump","Johnson &amp; Johnson","Johnson &amp; Johnson (NYSE:JNJ)","NYSE:JNJJ"],"articleSection":["Business"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/johnson-johnson-nysejnj-targets-at-least-1-billion-vaccines-in-2021-43106","url":"https:\/\/cablemanpro.com\/wallstreetpr\/johnson-johnson-nysejnj-targets-at-least-1-billion-vaccines-in-2021-43106","name":"Johnson & Johnson (NYSE:JNJ) Targets at least 1 Billion Vaccines in 2021 - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/johnson-johnson-nysejnj-targets-at-least-1-billion-vaccines-in-2021-43106#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/johnson-johnson-nysejnj-targets-at-least-1-billion-vaccines-in-2021-43106#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/02\/Johnson-Johnson.jpg","datePublished":"2020-05-13T12:01:33+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/johnson-johnson-nysejnj-targets-at-least-1-billion-vaccines-in-2021-43106#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/johnson-johnson-nysejnj-targets-at-least-1-billion-vaccines-in-2021-43106"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/johnson-johnson-nysejnj-targets-at-least-1-billion-vaccines-in-2021-43106#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/02\/Johnson-Johnson.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/02\/Johnson-Johnson.jpg","width":620,"height":413},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/johnson-johnson-nysejnj-targets-at-least-1-billion-vaccines-in-2021-43106#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"Johnson &#038; Johnson (NYSE:JNJ) Targets at least 1 Billion Vaccines in 2021"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e","name":"Greg Folin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg","caption":"Greg Folin"},"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/greg-folin"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/43106","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/32"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=43106"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/43106\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/42812"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=43106"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=43106"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=43106"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=43106"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}